Previous 10 | Next 10 |
The FDA approves Novocure's (NASDAQ: NVCR ) NovoTTF-100L System, combined with Eli Lilly's (NYSE: LLY ) Alimta (pemetrexed) and platinum-based chemo, for the first-line treatment of locally advanced or metastatic malignant pleural mesothelioma (MPM). More news on: NovoCure Limited, ...
Safety First: NASCAR driver Johanna Long and her helmet (Image Credit: Gearheads ) Bulletproof Investing: Week 78 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. T...
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have issued a proposed local coverage determination (LCD ) that provides coverage of Tumor Treating Fields, or Optune, for newly diagnosed glioblastoma (GBM). Pr...
Start Time: 08:00 End Time: 08:40 Novocure Limited (NVCR) Q1 2019 Earnings Conference Call May 02, 2019, 08:00 AM ET Company Participants Bill Doyle - Executive Chairman Asaf Danziger - CEO Wilco Groenhuysen - CFO Ely Benaim - CMO Ashley Cordova - SVP, Finance and IR C...
NovoCure ( NVCR ) Q1 results : Revenues: $73.3M (+40.7%). More news on: NovoCure Limited, Healthcare stocks news, Earnings news and commentary, Read more ...
The following slide deck was published by NovoCure Limited in conjunction with their 2019 Q1 earnings Read more ...
NovoCure (NASDAQ: NVCR ): Q1 GAAP EPS of -$0.13 beats by $0.02 . More news on: NovoCure Limited, Earnings news and commentary, Healthcare stocks news, Read more ...
Quarterly net revenues of $73.3 million, representing 41 percent growth versus the first quarter 2018 and 5 percent growth versus the fourth quarter 2018 Mesothelioma humanitarian device exemption application under FDA review Enrollment ongoing in four phase 3 pivotal trials, crea...
The study provides a definition for Tumor Treating Fields dose and sets a framework for future work on Tumor Treating Fields dosimetry and treatment planning The International Journal of Radiation Oncology, Biology, Physics, known in the field as the Red Journal, is the official journa...
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 17:30:15 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q2 2024 Earnings Call Jul 25, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q2 2024 Earnings Call Transcript
Quarterly net revenues of $150 million, up 19% year-over-year, with 3,963 active patients on therapy as of June 30, 2024 Positive results from Phase 3 METIS trial in brain metastases from non-small cell lung cancer presented at ASCO 2024 Novocure (NASDAQ: NVCR) today reported fi...